Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018-Reference-Cited by-同舟云学术

Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018

Published:2018-12 Issue:12 Volume:34 Page:1553-1563
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Brunham Liam R.^ORCID,Ruel Isabelle^ORCID,Aljenedil Sumayah,Rivière Jean-Baptiste,Baass Alexis,Tu Jack V.^ORCID,Mancini G.B. John,Raggi Paolo,Gupta Milan,Couture Patrick,Pearson Glen J.^ORCID,Bergeron Jean,Francis Gordon A.,McCrindle Brian W.^ORCID,Morrison Katherine,St-Pierre Julie,Henderson Mélanie,Hegele Robert A.^ORCID,Genest Jacques^ORCID,Goguen Jeannette,Gaudet Daniel,Paré Guillaume,Romney Jacques,Ransom Thomas,Bernard Sophie,Katz Pamela,Joy Tisha R.,Bewick David,Brophy James

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference43 articles.

1. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis;Akioyamen;BMJ Open,2017

2. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society;Nordestgaard;Eur Heart J,2013

3. Canadian Cardiovascular Society position statement on familial hypercholesterolemia;Genest;Can J Cardiol,2014

4. Simplified Canadian definition for familial hypercholesterolemia;Ruel;Can J Cardiol,2018

5. Imputation of baseline LDL cholesterol concentration in patients with familial hypercholesterolemia on statins or ezetimibe;Ruel;Clin Chem,2018

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world effectiveness of monoclonal antibody inhibitors of PCSK9 in patients with heterozygous familial hypercholesterolemia: A retrospective cohort study;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-09-06

2. Rapid DNA Diagnosis of Familial Hypercholesterolemia Due to the LDLR 15.8-Kilobase Deletion;CJC Open;2024-09

3. Genetic testing for familial hypercholesterolemia: a review of the current state of its implementation in Canada;CJC Open;2024-08

4. Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-07

5. Aféresis terapéutica en gestante con hipercolesterolemia familiar heterocigota;Nefrología;2024-05